Charlotte Keywood
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 17, 2023
Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches.
Journal: Expert review of neurotherapeutics
Published: August 08, 2020
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.
Journal: Neuropharmacology
Published: November 06, 2019
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
Journal: Experimental neurology
Published: October 29, 2019
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.
Journal: Neuropharmacology
Published: October 25, 2019
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 24, 2018
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: August 05, 2017
Metabotropic glutamate receptor 5: a target for migraine therapy.
Journal: Annals of clinical and translational neurology
Published: January 05, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 29, 2015
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
Journal: Brain : a journal of neurology
Published: February 12, 2015
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 13, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026